lectin
divers
group
protein
broadli
defin
nonimmunoglobulin
protein
exhibit
high
avid
glycoprotein
andor
glycolipidassoci
carbohydr
display
enzymat
activ
gene
encod
lectin
identifi
form
life
includ
plant
anim
virus
indic
evolutionari
conserv
inde
phylogenet
studi
indic
primit
immun
system
depend
lectinproteasemedi
opsonophagocytosi
lectin
differ
tissu
express
ligand
affin
structur
function
classifi
phylogeni
primari
tertiari
amino
acid
structur
carbohydraterecognit
domain
crd
howev
sever
inconsist
classif
system
review
glycosyl
form
posttransl
modif
glycosid
bond
organ
molecul
review
modif
play
essenti
role
express
function
mani
protein
eukaryot
prokaryot
cell
role
exampl
intercompound
interact
pathogen
immun
evas
eukaryot
viral
glycosyl
occur
host
cell
endoplasm
reticulum
er
golgi
apparatu
lectinglycan
interact
gener
achiev
hydrogen
bond
van
der
waal
forc
often
depend
cation
multival
interact
multipl
crd
multipl
cluster
target
glycan
order
achiev
suffici
affin
lectin
activ
role
human
lectin
includ
protein
modul
cell
growth
homeostasi
glycoprotein
found
surfac
sever
pathogen
divers
widespread
degre
lectin
act
patternrecognit
receptor
prr
recognis
pathogenassoci
molecular
pattern
pamp
glycan
nucleic
invad
microorgan
malign
apoptot
dead
host
cell
lead
induct
immun
respons
invad
pathogen
howev
relationship
lectin
virus
complex
addit
immun
evas
glycosyl
essenti
protein
express
assembl
entri
step
viru
replic
cycl
mani
virus
evolv
mechan
exploit
lectin
enhanc
infect
review
focus
human
lectin
role
viral
infect
concentr
welldescrib
lectin
mannosebind
lectin
mbl
ficolin
dendrit
cellspecif
grab
nonintegrin
dcsign
highlight
differ
effect
lectin
viral
infect
consequ
genet
variat
lectin
gene
suscept
viru
infect
altern
splice
product
gene
smap
encod
gene
cleav
respect
cleav
produc
convertas
thu
activ
complement
figur
upon
ligand
bind
lectin
undergo
conform
chang
bring
masp
serin
proteas
domain
within
close
proxim
thu
allow
proteolyt
autoactiv
via
cleavag
arginineisoleucin
bond
serin
proteas
domain
activ
appear
primarili
depend
may
autoactiv
transactiv
proenzym
might
mediat
either
heterodimer
masp
complex
cocomplex
separ
mblmasp
complex
complex
separ
bind
site
lectin
like
within
close
proxim
overlap
ident
smap
truncat
masp
protein
lack
serin
proteas
domain
put
role
modul
maspassoci
complement
activ
may
inhibit
activ
disrupt
intermasp
lectinmasp
cocomplex
masp
may
also
associ
lectin
pathway
complement
coagul
system
put
regulatori
function
activ
involv
facial
dysmorph
protein
embryon
develop
hypothesis
mbl
solubl
protein
collectin
ctype
lectin
collagen
gene
human
chromosom
mbl
primarili
express
liver
secret
blood
howev
lower
express
detect
elsewher
includ
mammalian
muscl
tissu
brain
often
follow
immun
challeng
mbl
monom
kda
molecular
weight
possess
typic
collectin
structur
ntermin
cysteinerich
domain
collagenlik
domain
cld
approxim
glyxaayaa
tandem
repeat
neck
region
crd
respons
ligand
bind
figur
monom
form
homotrimer
subunit
oligomeris
trimer
hexamer
structur
activ
complement
cascad
trimer
tetramer
mbl
common
physiolog
configur
figur
cld
form
mbl
trimer
hydrophob
interact
initi
tripl
coil
coil
format
neck
domain
stabilis
inter
intramonom
bridg
via
ntermin
cystein
oligomer
mbl
arrang
sertiform
structur
trimer
subunit
stretch
short
bundl
ntermin
region
short
amino
acid
sequenc
first
ntermin
glyxaayaa
repeat
creat
kink
bend
cld
howev
seen
minor
mbl
molecul
vivo
influenc
mbl
activ
signific
flexibl
exist
cldneck
cldnterminu
region
influenc
crd
posit
ligand
specif
masp
interact
masp
bind
centr
around
conserv
lysin
occupi
xaa
posit
cld
repeat
ligand
bind
induc
stretch
event
splay
mbl
trimer
subunit
bring
masp
togeth
enabl
proteolyt
autoactiv
trimerictetramer
mbl
may
repres
optim
configur
accommod
masp
autoactiv
mbl
exhibit
specif
pair
adjac
equatori
monosaccharid
group
present
termin
mannos
nacetylglucosamin
glcnac
nacetylmannosamin
lfucos
oligosaccharid
consist
presenc
conserv
glutamateprolineasparagin
epn
motif
crd
mbl
also
bind
phospholipid
nucleic
acid
support
role
clearanc
necrot
tissu
mbl
may
employ
higher
order
oligom
order
achiev
suffici
ligand
bind
via
multival
bond
recombin
mbl
therapeut
potenti
ebola
viru
ebov
infect
neutralis
viru
vitro
vivo
via
complement
activ
phagocytosi
direct
inhibit
glycoprotein
interact
dcsignlsign
receptor
howev
mbl
may
provir
effect
enhanc
ebov
infect
mediat
macropinocytosi
low
complement
condit
perhap
via
cell
receptor
figur
may
partial
explain
high
preval
allel
variant
confer
low
mbl
level
context
ebov
lower
mbl
level
may
prevent
excess
infect
mbl
also
enhanc
infect
brain
aidsassoci
dementia
complex
characteris
neuron
cell
death
cognit
deficit
howev
infect
rel
brain
cell
instead
shed
glycoprotein
internalis
via
receptor
neuron
cell
bound
shuttl
intracellular
mbl
vesicl
complex
er
golgi
apparatu
perhap
facilit
apoptosi
figur
mbl
deficiencyassoci
allel
correl
increas
suscept
infecti
diseas
howev
relationship
complex
tabl
homozygot
heterozygot
variant
allel
increas
risk
infect
diseas
progress
patient
carri
mblb
allel
higher
viral
load
sera
like
result
decreas
mblmediat
viral
elimin
snp
correl
increas
risk
perinat
infect
wherea
higher
mbl
level
confer
protect
low
serum
level
haplotyp
snp
associ
low
tcell
count
higher
viral
load
acceler
diseas
progress
contrast
studi
found
associ
variant
allel
suscept
infect
diseas
progress
although
mbl
level
chang
throughout
diseas
progress
mbl
serum
level
elev
patient
correl
good
respons
highli
activ
antiretrovir
therapi
haart
studi
suggest
protect
effect
diseas
progress
confer
variant
allel
mbl
variant
may
also
influenc
dengu
viru
infect
diseas
progress
mbl
defici
also
link
cytomegaloviru
cmv
reactiv
lung
liver
transplant
suscept
sarscov
yet
display
correl
iav
infect
correl
mblb
homozygot
snp
suscept
human
tcell
lymphotrop
viru
htlv
infect
observ
studi
suggest
mbl
variant
influenc
suscept
hcv
infect
diseas
progress
howev
other
show
associ
hcv
infect
diseas
progress
treatment
respons
one
studi
associ
mblb
protect
hcv
infect
associ
mblc
increas
suscept
mblb
associ
chronic
hepat
b
diseas
progress
wherea
mbld
display
caucasianspecif
associ
hepat
b
viru
hbv
persist
variant
snp
may
influenc
hbvassoci
hepat
liver
cirrhosi
hepatocellular
carcinoma
mbl
serum
level
role
perinat
hbv
infect
howev
one
studi
found
correl
variant
chronic
hbv
infect
studi
associ
polymorph
diseas
sever
geograph
popul
ethnic
diseas
sever
asymptomat
patient
age
rout
transmiss
studi
techniqu
sampl
size
must
taken
account
confound
factor
part
explain
discrep
studi
three
human
ficolin
describ
lficolin
mficolin
hficolin
sever
orthologu
identifi
genet
divers
lineag
anim
indic
ancient
ancestr
origin
lectin
includ
invertebr
ascidian
vertebr
chicken
nonhuman
primat
pig
human
ficolin
differ
sever
way
exampl
localis
human
bodi
capac
trigger
immun
respons
l
hficolin
protein
encod
gene
respect
encod
polypeptid
amino
acid
includ
signal
peptid
figur
review
gene
situat
chromosom
wherea
found
chromosom
gene
consist
eight
exon
wherea
compris
nine
exon
ficolin
monom
compris
ntermin
region
two
function
import
cystein
residu
cld
contain
glyxaayaa
repeat
linker
region
characterist
ctermin
globular
fibrinogenlik
domain
like
crd
fibrinogenlik
fbg
domain
recognis
specif
pathogenassoci
carbohydr
cld
respons
signal
induc
immun
respons
via
masp
protein
activ
oligomer
lficolin
mficolin
dodecam
compris
four
homotrimer
subunit
form
label
bouquet
structur
figur
wherea
hficolin
octadecamer
figur
like
mbl
ficolin
homotrim
stabilis
interact
hydrophob
residu
cld
oligomeris
intermonom
trimer
disulphid
bridg
ntermin
cystein
residu
hepatocyt
main
site
express
secret
l
h
ficolin
although
hficolin
also
highli
express
type
ii
alveolar
bronchial
epitheli
cell
despit
minor
lung
blood
express
mficolin
associ
surfac
peripher
blood
leukocyt
hficolin
abund
serum
ficolin
median
concentr
rang
follow
lficolin
median
rang
mficolin
median
rang
ficolin
bind
glcnac
nacetylgalactosamin
galnac
hficolin
also
bind
galnac
dfucos
mannos
lactos
mficolin
also
bind
sialic
acid
differ
ligand
specif
confer
sequenc
differ
bind
site
fbg
addit
lficolin
inner
bind
site
exhibit
great
structur
plastic
thu
allow
site
accommod
wide
varieti
ligand
independ
way
phosphocholin
moieti
bacteri
teichoic
acid
addit
acetyl
compound
exampl
major
bind
site
galactos
nacetylcystein
wherea
cooper
bind
among
other
like
mbl
ficolin
indirectli
activ
lytic
complement
pathway
via
masp
activ
induc
phagocytosi
opsonis
stimul
product
secret
inflammatori
cytokin
nitric
oxid
macrophag
interact
phagocyt
believ
mediat
function
signific
lysin
cld
residu
l
hficolin
respect
bind
calreticulin
phagocyt
cell
surfac
residu
respons
interact
masp
therefor
possibl
phagocyt
complement
effect
lficolin
competit
lficolin
may
also
clear
apoptot
necrot
host
cell
bind
apoptosisassoci
ligand
furthermor
lficolin
directli
prevent
viral
entri
host
cell
role
ficolin
clearanc
sever
pathogen
becom
increasingli
evid
howev
role
viral
clearanc
requir
greater
investig
lficolin
interact
virus
via
nlink
glycan
viral
envelop
glycoprotein
lficolin
bind
hcv
trigger
infectedcel
lysi
via
deposit
howev
lficolin
interact
abrog
hcv
glycoprotein
glycosyl
biolog
relev
level
recombin
oligomer
lficolin
display
similar
bind
activ
structur
serum
lficolin
neutralis
hcv
entri
dosedepend
manner
prevent
interact
cell
surfac
lipoprotein
receptor
scaveng
receptor
import
hcv
entri
monomer
lficolin
activ
complement
inhibit
hcv
entri
human
lficolin
porcin
neutralis
replic
infect
iav
vivo
porcin
reproduct
respiratori
syndrom
viru
vitro
respect
lficolin
directli
inhibit
iav
entri
promot
complementmedi
lysi
iav
infect
cell
iav
bind
sialyl
glycan
serum
hficolin
airway
viral
entri
enabl
hficolin
mediat
inhibit
iav
infect
direct
block
viral
aggreg
complement
activ
yet
unpublish
research
ren
et
al
implic
lficolin
mediat
complement
activ
follow
interact
mficolin
interact
pathogen
observ
despit
abil
activ
complement
mficolin
inhibit
iav
infect
major
mficolin
monocyt
granulocyt
membranebound
despit
lack
transmembran
tm
domain
associ
sialyl
membran
via
fbg
domain
candid
receptor
mficolin
gproteincoupl
receptor
upon
mficolinmedi
pathogen
interact
indirectli
activ
product
serum
mficolin
bind
sialic
acid
capsul
streptococcu
agalactia
via
fbg
activ
complement
howev
l
hficolin
found
interact
pathogen
sever
clinic
studi
monitor
part
ficolin
play
diseas
outcom
typic
focuss
one
two
factor
ficolin
gene
polymorph
tabl
ficolin
serum
concentr
one
haplotyp
associ
protect
hbv
infect
lficolin
level
higher
patient
acut
rather
chronic
hbv
infect
suggest
protein
directli
involv
immedi
clearanc
viru
influenc
subsequ
liver
diseas
lficolin
mutat
appear
confer
protect
effect
cmv
reinfect
liver
transplant
compar
wildtyp
lficolin
mutat
reduc
affin
toward
pentraxin
serum
protein
enhanc
lficolinmedi
complement
respons
aspergillu
fumigatu
suggest
polymorph
also
alter
affin
toward
cooper
protein
thu
affect
immun
respons
interestingli
snp
associ
low
serum
level
lficolin
yet
also
increas
lficolin
bind
hypothesis
unexpect
correl
due
higher
activ
exhaust
lficolin
protein
result
increas
bind
affin
although
investig
role
lficolin
viral
infect
polymorph
found
signific
suscept
diseas
sever
bacteri
diseas
includ
cutan
leishmaniasi
mycobacterium
lepra
pseudomona
aeruginosaassoci
bronchiectasi
streptococcu
pygonesassoci
rheumat
fever
chronic
rheumat
heart
diseas
howev
snp
associ
invas
pneumococc
diseas
respiratori
tract
infect
studi
rel
smallscal
geograph
limit
often
measur
serum
concentr
lficolin
confirm
relationship
polymorph
haplotyp
lficolin
level
therefor
rigor
larger
scale
studi
would
yield
reliabl
result
mficolin
snp
yet
report
role
viral
infect
howev
snp
associ
protect
lepraeassoci
leprosi
wherea
correl
suscept
perhap
alter
transcript
factor
affin
snp
associ
increas
mficolin
serum
level
nonsynonym
mutat
reduc
serum
level
ligand
bind
activ
wherea
abolish
serum
level
snp
correl
rheumatoid
arthriti
interestingli
express
gene
among
other
upregul
chronic
hcv
patient
possess
cc
genotyp
promot
snp
associ
favour
respons
pegyl
ribavirin
treatment
suggest
possibl
role
mficolin
clearanc
hcv
howev
studi
need
studi
correl
hficolin
snp
infecti
diseas
serum
ficolin
level
depend
express
allel
homozygot
particular
snp
exhibit
highest
lowest
level
wherea
heterozygot
display
intermedi
level
ficolin
specif
snp
associ
low
level
lficolin
tend
caus
higher
suscept
infect
lficolin
level
significantli
increas
serum
hcvinfect
individu
concentr
correl
sever
fibrosi
chronic
hcvassoci
liver
damag
also
reduc
level
lficolin
express
chronic
hcvinfect
patient
abnorm
alanin
aminotransferas
alt
level
serum
concentr
lficolin
correl
alt
level
alt
known
marker
fibrosi
inflamm
success
therapi
alt
hcv
rna
level
patient
decreas
normal
valu
follow
decreas
lficolinlevel
suggest
correl
alt
rna
level
diseas
outcom
result
lficolin
activ
higher
lficolin
serum
concentr
also
appear
confer
protect
effect
microorganisminduc
inflamm
allerg
respiratori
diseas
lficolin
level
higher
acut
sever
case
plasmodium
falciparumbas
malaria
rather
mild
case
low
hficolin
serum
level
correl
fever
neutropenia
paediatr
cancer
patient
treat
chemotherapi
consequ
complement
activ
subsequ
activ
humor
immun
system
pathogen
thu
enhanc
adapt
immun
respons
memori
lectin
also
directli
interact
immun
compon
enhanc
antimicrobi
respons
mbl
bind
serum
prr
serum
amyloid
p
compon
sap
via
cld
promot
complement
activ
opsonophagocytosi
candida
albican
figur
requir
enhanc
activ
classic
complement
pathway
natur
antibodi
produc
without
prior
exposur
infect
immunis
import
protect
individu
expos
pathogen
first
time
neonat
abl
initi
complement
alon
howev
mild
acidosi
reduc
calcium
found
infectioninflamm
addit
bind
site
expos
ficolin
fbg
allow
complex
format
natur
immunoglobulin
g
nigg
allow
indirect
niggbas
phagocytosi
via
lficolin
opsonis
lead
stronger
immun
respons
figur
interact
lficolin
enhanc
bind
aspergillu
fumigatu
induct
deposit
similarli
mficolin
bind
sialic
acid
manner
via
fbg
domain
mficolin
complex
enhanc
phagocytosi
apoptot
necrot
cell
hficolin
may
also
cooper
howev
specif
interact
two
report
similar
nigg
ficolin
complex
infectioninflamm
condit
significantli
increas
interact
acut
phase
protein
creactiv
protein
crp
lficolin
lead
stronger
classic
lectinmedi
complement
respons
pseudomona
aeruginosa
ph
calciumsensit
bind
site
ficolin
fbg
domain
enabl
bind
crp
later
phase
infectioninflamm
condit
also
enhanc
interact
membran
mficolin
crp
thu
block
mficolin
bind
pamp
curtail
product
allow
restor
homeostasi
upon
infect
injuri
dendrit
cell
dc
express
prr
dcsign
play
role
antigen
captur
internalis
contribut
matur
migrat
dc
secondari
lymphoid
organ
present
antigen
rest
tcell
dctcell
interact
mediat
transient
interact
dcsign
tcell
surfac
human
ctype
lectin
monomer
structur
compris
ctermin
crd
follow
flexibl
neck
region
form
coil
coil
upon
trimeris
consist
acid
repeat
involv
oligomer
tm
region
follow
cytoplasm
ntermin
region
respons
internalis
via
dileucin
tyrosin
motif
figur
adjac
chromosom
gene
encod
membranebound
ctype
lectin
lsign
dcsignr
protein
highli
homolog
dcsign
protein
perform
similar
role
dcsign
differ
tissu
distribut
express
express
mainli
liver
lymph
node
activ
tetramer
dcsign
figur
organis
dc
surfac
nanoclust
mediat
neck
region
permit
interact
pathogen
varieti
size
larg
nm
across
seen
measl
viru
mv
level
dcsign
express
import
optim
viru
bind
partial
explain
rel
effici
bind
exhibit
dc
rather
dcsign
cell
furthermor
virusbind
capac
dcsign
also
govern
cell
type
viru
replic
cell
type
caus
subtl
chang
glycosyl
profil
viral
glycoprotein
dcsign
preferenti
bind
fucosyl
high
mannosetyp
oligosaccharid
use
differ
bind
site
differ
avid
depend
configur
mannos
fucos
residu
glycan
ligand
well
present
target
molecul
pathogen
surfac
dcsign
exploit
sever
pathogen
host
cell
bind
entri
current
gener
accept
model
dcsignmedi
infect
utilis
dcsign
cell
dc
transport
virion
site
mucos
membran
tcell
target
lymphoid
tissu
review
addit
primari
receptor
coreceptor
dcsign
also
recognis
result
activ
downstream
process
virion
shuttl
proteasom
aid
interact
cytoskelet
phosphoprotein
dcsign
degrad
mhc
class
ii
present
tcell
altern
exploit
dcsign
dcsign
activ
modul
cytokin
respons
enhanc
transcript
genom
independ
dcsign
modul
tlrinduc
cytokin
genom
express
figur
dcsign
bind
also
enhanc
glycoprotein
interact
entri
result
dcsignbound
intact
virion
nonfusogen
internalis
specialis
nonlysosom
lowph
endosom
virion
abl
maintain
stabil
infect
sever
day
without
need
replic
whether
virion
degrad
maintain
dc
depend
sever
factor
includ
nlink
glycan
composit
dcinternalis
stabl
transfer
tcell
upon
dctcell
contact
protect
virion
adhes
molecul
receptor
rapidli
accumul
dctcell
interfac
enabl
transfer
across
infecti
synaps
bind
tcell
receptor
nef
may
prevent
dcsignbound
internalis
enhanc
transinfect
transinfect
like
occur
matur
dc
effici
protect
viru
endocytosi
wherea
immatur
dc
effici
degrad
contrast
bind
dcsign
may
slow
dc
matur
express
mhc
class
ii
order
prevent
immun
respons
prime
cell
transinfect
lectin
implic
transinfect
matur
dcexpress
sialic
acidbind
iglik
lectin
bind
sialyllactosecontain
gangliosid
surfac
interestingli
featur
acquir
immunodefici
syndrom
aid
gradual
deplet
dc
level
increas
risk
opportunist
infect
result
interact
certain
condit
prime
dc
apoptosi
excess
activ
proapoptot
kinas
sever
virus
utilis
dcsign
differ
purpos
exampl
mani
virus
use
dcsign
attach
factor
transinfect
mv
ebov
sarscov
iav
hcv
cmv
other
use
dcsign
fusion
internalis
human
hcv
lsign
similarli
exploit
mani
virus
glycoproteinmedi
attach
internalis
receptor
observ
hcv
sarscov
marburg
viru
ebov
howev
dcsign
lsign
differ
viral
interact
polymorph
neck
region
lsign
highli
variabl
polymorph
wherea
dcsign
gener
conserv
furthermor
lsign
bind
promot
infect
certain
virus
effici
dcsign
exampl
wnv
sever
dcsign
isoform
exist
result
altern
splice
result
membranebound
solubl
form
altern
cytoplasm
crd
region
miss
tm
domain
variabl
neck
domain
repeat
region
rel
littl
known
physiolog
immun
role
solubl
dcsign
sdcsign
tetramer
sdcsign
detect
bodili
fluid
cytoplasm
dcsign
cell
howev
unknown
protein
secret
interestingli
cmv
interact
sdcsign
via
gb
glycoprotein
manner
interact
membranebound
dcsign
possibl
enhanc
viral
uptak
dc
consider
purifi
select
pressur
exert
region
encod
dcsign
neck
region
prevent
accumul
polymorph
global
popul
maintain
typic
neck
region
size
repeat
fact
gene
display
variant
heterozygos
prototyp
neck
region
repeat
allel
present
global
popul
length
tetramer
structur
constrain
crd
partial
influenc
specif
certain
virus
glycan
structur
certain
geometr
configur
despit
conserv
eight
low
frequenc
allel
encod
dcsign
protein
two
neck
region
repeat
document
differ
dcsign
isoform
found
cell
surfac
affect
dcsign
multimeris
therefor
could
theori
influenc
suscept
infect
mutat
dcsign
enhanc
captur
transinfect
studi
identifi
signific
dcsign
exon
neck
region
snp
context
observ
dcsign
variant
less
five
neck
region
repeat
rare
frequent
chines
popul
associ
protect
transmiss
heterozygot
variant
atyp
number
neck
region
repeat
five
also
associ
protect
infect
cmv
observ
interact
sdcsign
via
gb
glycoprotein
manner
interact
membranebound
dcsign
possibl
enhanc
viral
uptak
dc
promot
snp
implic
resist
suscept
sever
infecti
diseas
howev
correl
often
limit
particular
geograph
popul
snp
aa
genotyp
confer
protect
dvbase
dengu
fever
perhap
due
reduc
transcript
factor
bind
activ
decreas
suscept
dc
infect
suppress
symptom
ggag
genotyp
hand
increas
suscept
dengu
haemorrhag
fever
result
higher
dcsign
express
immun
activ
dv
allel
associ
protect
infect
wherea
implic
higher
suscept
parenter
infect
snp
also
implic
perinat
transmiss
snp
influenc
liver
diseas
sever
hcv
patient
aggg
genotyp
preempt
improv
prognosi
sarscov
patient
addit
dcsign
sever
membranebound
lectin
exploit
virus
enhanc
infect
exploit
ctype
lectin
mannos
receptor
howev
significantli
less
solubl
lectin
involv
enhanc
infect
nevertheless
candid
addit
mbl
identifi
solubl
pulmonari
collectin
spa
spd
inhibit
iav
haemagglutinin
activ
viral
aggreg
enhanc
neutrophil
immun
respons
spa
also
role
enhanc
phagocytosi
via
host
spa
receptor
may
exploit
iav
caus
excess
lung
inflamm
furthermor
spd
bind
neutralis
sever
strain
virion
agglutin
spatial
block
interact
howev
spd
enhanc
transinfect
dc
tcell
similarli
spa
prevent
cisinfect
tcell
yet
enhanc
cisinfect
dc
transinfect
tcell
spa
also
enhanc
entri
fusion
respiratori
syncyti
viru
rsv
galectin
solubl
lectin
vari
structur
oligomeris
exhibit
specif
glycan
contain
bind
human
cell
receptor
thu
allow
protein
directli
stabilis
crosslink
interact
enhanc
viral
attach
entri
similarli
crosslink
interact
cell
surfaceassoci
protein
disulphid
isomeras
enhanc
fusion
entri
hand
intracellularli
bridg
gag
interact
protein
x
alix
promot
bud
membraneassoci
lectin
gener
describ
exploit
virus
entri
howev
signific
role
viral
clearanc
ctype
lectin
langerin
express
surfac
langerhan
cell
epitheli
dc
subset
bind
mannosecontain
glycan
unlik
dcsign
langerin
mediat
internalis
birbeck
granul
viral
degrad
antigen
present
effici
prevent
transmiss
langerin
also
respons
captur
internalis
mv
virusassoci
glycan
emerg
potenti
target
antivir
therapi
preliminari
clinic
trial
regular
mbl
replac
therapi
mbldefici
patient
use
plasmapurifi
mbl
attempt
result
normal
longterm
complement
activ
opsonis
activ
obviou
advers
autoimmun
effect
product
purif
safe
activ
function
therapeut
mbl
feasibl
requir
optimis
therapi
use
recombin
mbl
avoid
ethic
issu
allow
costeffect
largescal
product
phase
trial
prove
recombin
mbl
toler
safe
effect
restor
mbl
activ
mbldefici
patient
mild
advers
effect
due
complex
structur
recombin
activ
mbl
complic
expens
produc
wherea
recombin
chimaer
lectin
rcl
exhibit
superior
protect
potenc
costeffect
safeti
antivir
efficaci
rcl
consist
structur
similar
lectin
mbl
lficolin
studi
like
lficolin
activ
mbllficolin
rcl
form
dodecam
exhibit
stronger
mbl
crdmediat
ligand
bind
like
due
enhanc
crd
flexibl
possess
masp
calreticulinbind
site
consist
mbl
lficolin
fragment
display
strong
complement
activ
opsonophagocyt
properti
physiolog
level
neutralis
ebov
pseudotyp
infect
moder
neutralis
hendra
nipah
viru
infect
possess
mbl
maspbind
site
antiiav
activ
vitro
enhanc
complement
activ
induc
viral
aggreg
inhibit
iav
envelop
glycoprotein
activ
therapeut
advantag
exhibit
reduc
associ
diminish
coagul
system
activ
demonstr
effici
antiiav
effect
vivo
maintain
cytokin
inflammatori
balanc
advantag
host
similar
therapeut
approach
lectin
research
exampl
specif
mutagen
engin
human
spd
enhanc
iav
bind
clearanc
murin
surviv
vivo
porcin
spd
neutralis
wider
rang
iav
infect
potent
recombin
human
spd
vitro
ex
vivo
howev
may
immunogen
human
therefor
develop
necessari
although
ficolin
use
clinic
antivir
therapi
given
promis
mbl
therapi
potenti
therapeut
administr
ficolin
viru
infect
due
essenti
conserv
natur
nlink
glycosyl
site
life
cycl
mani
envelop
virus
acetyl
sugar
potenti
target
direct
entri
inhibit
viral
clearanc
lficolin
administr
inde
document
hcv
strain
resist
antivir
effect
ficolin
ficolin
could
use
combin
antibodi
therapi
howev
degre
antibodi
interact
complement
compon
vari
exampl
mbl
prevent
rather
enhanc
neutralis
activ
antibodi
moreov
import
complement
protect
infecti
diseas
vari
pathogen
strain
exampl
hcv
genotyp
heavili
glycosyl
glycoprotein
appear
suscept
lectinmedi
neutralis
interfer
immun
system
particular
complement
system
extrem
complex
may
lead
potenti
harm
excess
immun
activ
therefor
strict
caution
test
impos
passiv
immunotherapi
activ
trigger
immun
respons
fight
infect
avoid
excess
stimul
complement
system
therefor
lficolin
could
sole
act
entri
inhibitor
sitedirect
mutagenesi
residu
fbg
domain
respons
masp
interact
interact
phagocyt
receptor
altern
approach
use
carbohydratebind
agent
cba
interact
viral
glycoprotein
order
inhibit
dcsign
interact
tend
xenogen
algal
cyanobacteri
lectin
griffithsin
grft
cyanovirinn
cvn
scytovirin
svn
oscillatoria
agardhii
agglutinin
oaa
synthet
antibiot
pradimicin
act
cba
inhibitor
interact
dcsign
vitro
vivo
ex
vivo
lectin
therefor
potenti
use
antivir
microbicid
elicit
nontox
nonimmunogen
neutralis
mammal
vitro
vivo
oaa
hybrid
opa
molecul
synthet
chimera
pseudomona
fluorescen
agglutinin
notabl
uniqu
interact
oligosaccharid
rather
termin
mannos
grft
also
antivir
activ
hcv
sarscov
sever
coronavirus
vitro
vivo
grft
reduc
viral
titr
patholog
japanes
encephalitisinfect
hcvinfect
sarscovinfect
mice
administ
intraperiton
subcutan
intranas
respect
cvn
inhibit
entri
hcv
mv
human
herpesviru
vitro
prevent
infect
mortal
iavinfect
mice
ferret
administ
intranas
howev
ineffect
administ
subcutan
nevertheless
sever
cba
small
viral
target
rang
like
result
divers
viral
glycoprotein
exampl
certain
cba
inhibit
hcv
infect
yet
ineffect
herp
simplex
viru
vesicular
stomat
viru
rsv
parainfluenza
adenoviru
type
cmv
herpesviru
type
vaccinia
viru
mitogen
activ
affect
cytokin
express
short
plasma
halflif
characterist
nonhuman
immun
protein
use
human
milieu
overcom
linkerextend
pegyl
cvn
produc
order
extend
protein
halflif
dampen
immunogen
cytotox
yet
maintain
antivir
activ
grft
elicit
far
greater
effect
cvn
svn
caus
signific
mitogen
inflammatori
cytotox
irrit
effect
despit
possibl
grft
suffici
stabl
therapeut
administr
subcutaneouslyadminist
grft
remain
activ
mice
sever
day
inject
minim
advers
effect
ancient
origin
multipl
physiolog
function
lectin
part
evolutionari
arm
race
human
immun
system
infect
virus
lectin
evolv
abil
bind
divers
ligand
limit
viral
infect
rang
immun
activ
virus
evolv
highli
glycosyl
protein
abl
bind
lectin
enhanc
attach
entri
transmiss
yet
evad
lectinmedi
neutralis
despit
viral
exploit
lectin
potenti
prime
immun
system
enhanc
viral
clearanc
emerg
field
alreadi
yield
novel
antivir
therapi
understand
specif
lectin
virushost
dynam
remain
incomplet
improv
understand
interact
aid
develop
protein
antivir
therapeut
